Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result
Crossref DOI link: https://doi.org/10.1007/s10238-015-0373-2
Published Online: 2015-07-12
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cai, Shaohang
Yu, Tao
Jiang, Yegui
Zhang, Yonghong
Lv, Fangfang
Peng, Jie
Text and Data Mining valid from 2015-07-12